Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity

Michèle Guerre-Millo, Philippe Gervois, Eric Raspé, +9

Journal of Biological Chemistry

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

Giulia Chinetti, F. Gbaguidi, S. Griglio, +8

Circulation

Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I

Geneviève Martin, Hélène Duez, Christophe Blanquart, +6

Journal of Clinical Investigation

PPAR-α–Null Mice Are Protected From High-Fat Diet–Induced Insulin Resistance

Michèle Guerre-Millo, Christine Rouault, Philippe Poulain, +7

Diabetes

Reduction of Atherosclerosis by the Peroxisome Proliferator-activated Receptor α Agonist Fenofibrate in Mice

Hélène Duez, Yu‐Sheng Chao, Melba Hernandez, +11

Journal of Biological Chemistry

Fibrates Suppress Fibrinogen Gene Expression in Rodents Via Activation of the Peroxisome Proliferator-Activated Receptor-

Maaike Kockx, Philippe Gervois, Philippe Poulain, +6

Blood

Regulation of Human ApoA-I by Gemfibrozil and Fenofibrate Through Selective Peroxisome Proliferator-Activated Receptor α Modulation

Hélène Duez, Bruno Lefebvre, Philippe Poulain, +12

Arteriosclerosis Thrombosis and Vascular Biology

Is disease progression the major factor in morphine ‘tolerance’ in cancer pain treatment?

E. Collin, Philippe Poulain, Annie Gauvain‐Piquard, +2

Pain

PPARa activators improve insulin sensitivity and reduce adiposity

Michèle Guerre-Millo, Philippe Gervois, Eric Raspé, +9

Journal of Biological Chemistry

ObesityMetabolic SyndromeInsulin SignalingMedicineInsulin Management +6

Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice

Anne Tailleux, Muriel Bouly, Gérald Luc, +7

Arteriosclerosis Thrombosis and Vascular Biology